Resource Management

MRM Health is a clinical-stage biopharmaceutical company based in Ghent, Belgium, specializing in the development of next-generation live biotherapeutic products (LBPs) for inflammatory, autoimmune, and metabolic diseases. The company utilizes its proprietary M-Line (also known as CORAL) platform to rationally design consortia of commensal bacteria that work synergistically to restore the gut microbiome and target specific disease pathways. Its lead candidate, MH002, is currently in Phase 2 clinical development for the treatment of ulcerative colitis and the orphan disease pouchitis. MRM Health was founded as a joint venture between MRM Technologies and the VIB (Flanders Institute for Biotechnology) and has established strategic partnerships with industry leaders such as Biocodex and IFF.